Artificial oxygen-carriers in organ preservation: Dose dependency in a rat model of ex-vivo normothermic kidney perfusion.

J. Jägers,M. Cantore,M. Kirsch,O. Karaman,K. Ferenz

DOI: https://doi.org/10.1111/aor.14264

2022-04-18

Artificial Organs

Abstract:INTRODUCTION Organ preservation through ex-vivo normothermic perfusion (EVNP) with albumin-derived perfluorocarbon-based artificial oxygen carriers (A-AOCs) consisting of albumin-derived perfluorodecalin-filled nanocapsules prior to transplantation would be a promising approach to avoid hypoxic tissue-injury during organ storage. METHODS The kidneys of 16 rats underwent EVNP for 2h with plasma-like solution (5% bovine serum albumin, Ringer-Saline, inulin) with or without A-AOCs in different volume fractions (0, 2, 4 or 8%). Cell death was determined using TdT-mediated dUTP-biotin nick end labeling (TUNEL). Aspartate-transaminase (AST) activity in both perfusate and urine as well as the glomerular filtration rate (GFR) were determined. The hypoxia inducible factors 1α and 2α (HIF-1α und -2α) were quantified in tissue homogenates. RESULTS GFR was substantially decreased in the presence of 0, 2 and 8% A-AOC but not of 4%. In accordance, hypoxia mediated cell death, as indicated by both AST activity and TUNEL-positive cells, was significantly decreased in the 4% group compared to the control group. The stabilization of HIF 1α and 2α decreased with 4% and 8% but not with 2% A-AOCs. CONCLUSION The dosage of 4% A-AOCs in EVNP was most effective in maintaining the physiological renal function.

Engineering,Medicine